+44 (0)20 8817 5296info@tritrials.com

Resources

What do you have in place for ICH E6 Rev 2, and what do you need?

How Can You Claim to Do Risk-Based Monitoring If You Don’t Know How Much Noise Is In Your System?   My last article was concerned with the overall lack of using available data and technology to make better decisions, which is endemic within industry as well as people’s personal lives. In fact, Conway’s Law would suggest that how individuals…

Read More

Better risk-based thinking will help produce better risk-based monitoring

How People Can Get Better At Risk-Based Thinking and Improve Their Organization’s RBM Misinformation about risk based monitoring abounds. In fact, the level of misinformation on the topic long ago surpassed the level of correct information. I wanted to provide some practical insight as to why risk-based monitoring is so important to the work you do. There is a…

Read More

Press Release – TRI become the first MCC Solution Provider

Following a long standing working relationship between Triumph Research Intelligence (TRI) and the Metrics Champion Consortium (MCC), TRI will now make the IP developed by the MCC’s Risk Management working group available as part of the risk assessment and management module in their OPRA platform. The need for a centralized, easy to use, auditable protocol risk assessment and management…

Read More

Press Release – Advanced Clinical selects TRI and OPRA for risk-based monitoring

Following a six month long industry wide technology assessment, Advanced Clinical, (Advanced) has selected Triumph Research Intelligence (TRI) as their RBM technology and services partner. TRI will be providing the OPRA platform for all of Advanced’s studies whose sponsors have requested a risk-based approach to monitoring with the objective of improving operational efficiency, quality, and patient safety. Conjointly, TRI…

Read More

Trial oversight in SMB Pharma – Reflections on 6th CQOF

Firstly, I wanted to say what a great event the CQOF was – well attended, well organised, great presentations and great dialogue. Well done Kristen and her team. There were a few more attendees than last year which is always positive, but a very different demographic and feel to the event. The focus on the relationship between trial oversight…

Read More

TRI to Sponsor and Present at 6th Clinical Quality Oversight Forum

Please feel free to come by our booth for a demo of OPRA, the risk-based monitoring platform, and to find out how we can help you kick-start your RBM program. Our CEO, Duncan Hall will be presenting on the following RBM and quality oversight related topic: Identifying Relevant Risk Indicators for Each Stage of the Trial to Optimize Quality…

Read More

European Clinical Insights Press Release

TRI were delighted to take part in such a valuable set of meetings and have just been quoted in OmniComm’s recent press release regarding the event. TRI pride themselves on supporting the growth in uptake and understanding of risk-based monitoring within our industry and as such, events like these provide the perfect platform to understand the needs and challenges…

Read More

TRI complete second round of funding

Raleigh, NC, July 20th 2015 – TRI, the risk-based monitoring company, is very excited to announce the completion of their second round of funding, and the furthering of its partnership with Peter Brummitt and Bev Mehentee, co-founders of Wider Perspectives Ltd. TRI is enjoying ongoing and rapid growth thanks to strong market demand both for OPRA, the risk-based monitoring…

Read More

OPRA, the RBM platform: Autumn demo schedule

Each demo will be a 30 min live presentation which will cover the fundamentals of TRI’s four pillars of risk-based monitoring: Identify, Manage, Mitigate and Report (on site quality risk). Please follow the link to register for any of the demos: OPRA demo registration

Read More

TRI releases OPRA Evolution 4

First – a little bit of background: TRI are committed to ensuring OPRA is the most up to date, usable and fully featured RBM platform available. In order to achieve this we need to do three things. 1 – listen to our customers – what do you like? what do you want to improve? what do you want to…

Read More

Clinical Insight Symposia

TRI will be speak on RBM at the London (June 3rd) and Basel (June 11th) events. Please click the link below to register for any or all of the events. We look forward to seeing you there. Registration

Read More

Why is the funnel plot so important to risk-based monitoring?

Before I dive into some of the detail about funnel plots, I wanted to start by highlighting a few key concepts, driven by risk-based monitoring (RBM) which are likely to come into play, whatever your specific approach to RBM is going to be:   You want to start assessing site quality risk as early in the trial as possible,…

Read More